OverviewChartNewsTraderScreen

BVT Put 100 NVO 21.03.2025/  DE000VD3N4D2  /

Frankfurt Zert./VONT
2024-08-09  8:02:58 PM Chg.-0.070 Bid8:59:45 PM Ask8:59:45 PM Underlying Strike price Expiration date Option type
0.280EUR -20.00% -
Bid Size: -		 -
Ask Size: -		 Novo Nordisk 100.00 USD 2025-03-21 Put
TeleTrader 08-07 Europe higher premarket amid earnings reports
TeleTrader 07-05 Novo Nordisk slammed over undisclosed payments
GlobeNewswire 07-02 Notified Celebrates Winners of 2024 IR Magazine European Awards
GlobeNewswire 06-28 SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteri...
GlobeNewswire 06-27 Arch Biopartners Announces GMP Manufacturing of Cilastatin Drug Product
GlobeNewswire 06-24 Veru Announces Safety and Body Composition Data from Two Late-Breaker Presentations at the American ...
GlobeNewswire 06-18 Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesit...
GlobeNewswire 06-18 Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for ...
GlobeNewswire 06-17 Veru Reminds Shareholders to Vote in Advance of Tomorrow’s Deadline for 2024 Annual Meeting of Share...
TeleTrader 06-15 Novo Nordisk CEO to voluntarily testify before US committee
GlobeNewswire 06-14 Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
GlobeNewswire 06-13 Aeterna Zentaris Announces Last Patient Last Visit in Pivotal DETECT-Trial for the Diagnosis of Chil...
GlobeNewswire 06-13 Biosplice Announces Collaboration with Novo Nordisk in Diabetes
GlobeNewswire 06-11 Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next...
GlobeNewswire 06-10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 06-10 Veru to Present at the American Diabetes Association's 84th Scientific Sessions
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 06-03 Aeterna Zentaris and Ceapro Complete Merger Transaction
GlobeNewswire 05-31 Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire 05-30 Anaqua Annual User Experience Conference to Feature Keynotes from Microsoft, SAP, USPTO, and More
GlobeNewswire 05-22 Veru to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 05-15 Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Cl...
GlobeNewswire 05-15 Aeterna Zentaris Reports First Quarter 2024 Financial Results
GlobeNewswire 05-14 Veru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Sci...
GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...